Prevalence of actionable pharmacogenetic variants and high‐risk drug prescriptions: A Swiss hospital‐based cohort study

Documenti analoghi

• Patterns of pharmacogenetic variation in nine biogeographic groups
  di: Sophia Hernandez, et al.
  Pubblicazione: (2024)
• Inadequate representation of individuals of African ancestry in pharmacogenetics of tamoxifen research
  di: Keneuoe Cecilia Nthontho, et al.
  Pubblicazione: (2024)
• QPGx‐CARES: Qatar pharmacogenetics clinical applications and research enhancement strategies
  di: Rania Abdel‐latif, et al.
  Pubblicazione: (2024)
• Reply to “Inadequate representation of individuals of African ancestry in pharmacogenetics of tamoxifen research”
  di: Bianca Kruger, et al.
  Pubblicazione: (2024)
• Real‐world implementation of DPYD and UGT1A1 pharmacogenetic testing in a community‐based cancer center
  di: Megan Muldoon, et al.
  Pubblicazione: (2024)